Signostics, a Kirkland, Washington-based developer of handheld ultrasound devices and bladder scanners, received a $35m investment from KKR.
The company intends to use the funds to pursue medical innovations and to expand and accelerate global marketing and distribution for new products.
Founded in Adelaide, Australia, and led by Kevin Goodwin, Chief Executive Officer, Signostics develops handheld ultrasound technology. The company recently released the patented SignosRT Bladder Scanner in 2014 – a device that utilizes ultrasound technology to automate detection of the bladder and calculation of its volume. Signostics will be releasing a new product in 2016 and is initiating work on a series of advancements in ultrasound technology.
The existing product portfolio has gained regulatory approval in Australia, the U.S., Canada, Japan, Singapore and Europe and currently exports to countries around the world.
FinSMEs
16/11/2015